Advanced Filters
noise

Parkinson's Disease Clinical Trials

A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 626 clinical trials
D Dulce Maroni, PhD

Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease

This is an open-label, non-randomized, proof-of-concept comparison of clinical vs. research stimulation patterns in patients with Parkinson's disease (PD) being treated with Deep Brain Stimulation (DBS) through the Medtronic Percept PC DBS device. The investigators hypothesize that stimulation patterns designed to better target excessive synchrony in a patient-tailored manner may …

19 - 80 years of age All Phase N/A
J Jacqueline Burre, PhD

Parkinson's Disease Biomarkers in Nerve Cells in the Gut

Parkinson's disease affects all the nerve cells in the body, including the ones in the gut. The gut contains its own nervous system, the enteric nervous system, and can be thought of as a "second brain". This second brain can reflect what is going on in the actual brain. This …

45 - 75 years of age All Phase N/A
Z Zhao Guohua, Doctor

Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease

To evaluate the efficacy and safety of tenofovir disoproxil fumarate in the treatment of Parkinson's disease. The changes of motor symptoms and the occurrence of adverse reactions in early Parkinson's disease patients who took tenofovir disoproxil fumarate and did not take Tenofovir disoproxil fumarate at different time points were compared.

18 - 65 years of age All Phase 1
A Aasef G Shaikh, MD PhD

Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease

Inability to align and refocus the eyes on the objects at different depths, i.e., vergence impairment, frequently affects the quality of life in patients with Parkinson's disease. Our study aims to understand the location-specific effects of subthalamic region deep brain stimulation on vergence by integrating the patient-specific deep brain stimulation …

years of age All Phase N/A
Y Yurdagul Bahran Mustu, MD.

Action Observation and Motor Imagery Therapy in Parkinson's Disease

In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in Parkinson's disease (PD). Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons …

18 - 65 years of age All Phase N/A

Movement Improves Brain Health and Cognition in Parkinson's Disease

The aim of this clinical trial is to investigate the effects of L-serine supplementation on cognitive decline and psychosocial functioning in older adults with late-life depression (LLD). The study will evaluate changes in depressive symptoms, neural and cognitive functioning, and will assess neurophysiological, metagenomic, and biochemical alterations associated with L-serine …

30 - 80 years of age All Phase N/A
J Jeffrey M Hausdorff, Prof.

Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna

Parkinson's disease (PD) affects over 10 million worldwide, causing unstable gait and falls in 70% of patients despite medication. This leads to confidence loss, isolation, fractures, and hospitalizations. Treadmill training, augmented by mechanical/virtual-reality triggers, has proven effective in enhancing gait and reducing falls. However, underlying treadmill training mechanisms are unclear. …

years of age All Phase N/A
N Niloufar Malakouti, M.D.

Accelerated TMS for Freezing of Gait in Parkinson's Disease

The goal of this clinical trial is to learn whether a personalized brain stimulation method called repetitive transcranial magnetic stimulation (rTMS), combined with walking exercises, is a practical and tolerable approach to help people with Parkinson's disease who experience freezing of gait (FOG). FOG is a disabling symptom where people …

50 - 80 years of age All Phase N/A
R Research Coordinator

Sustained Release Oral Formulation for Treatment of Parkinson's Disease

Achieving sustained blood levels of carbidopa/levodopa has been a challenge in the treatment of PD and although levodopa remains the most commonly used drug, motor fluctuations remain a major disability especially in advanced Parkinson's disease. The aim of this study is to determine the efficacy of a novel oral carbidopa-levodopa …

18 - 65 years of age All Phase 0
J Julius Welzel

Steps Against the Burden of Parkinson's Disease - RCT Kiel

Parkinson's disease (PD) affects over 10 million worldwide, causing unstable gait and falls in 70% of patients despite medication. This leads to confidence loss, isolation, fractures, and hospitalizations. Treadmill training, augmented by mechanical/virtual-reality triggers, has proven effective in enhancing gait and reducing falls. However, underlying treadmill training mechanisms are unclear. …

years of age All Phase N/A

Simplify language using AI